Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chunxia Chen

Showing results (241-250 of 264) with videos related to

Pageof 27
Sort By:
Journal for Immunotherapy of Cancer|June 21, 2023
Discovery of a novel dual-targeting D-peptide to block CD24/Siglec-10 and PD-1/PD-L1 interaction and synergize with radiotherapy for cancer immunotherapyWenhui Shen, Peishang Shi, Qingyu Dong, et al.
International Journal of Biological Macromolecules|October 20, 2018
Yulangsan polysaccharide inhibits 4T1 breast cancer cell proliferation and induces apoptosis in vitro and in vivoNi Qin, Shiyin Lu, Ning Chen, et al.
Acta Pharmaceutica Sinica. B|September 30, 2021
Tryptophan 2,3-dioxygenase 2 controls M2 macrophages polarization to promote esophageal squamous cell carcinoma progression <i>via</i> AKT/GSK3<i>β</i>/IL-8 signaling pathwayYumiao Zhao, Jiaxin Sun, Yin Li, et al.
Nature Medicine|October 9, 2007
Deacetylase inhibition promotes the generation and function of regulatory T cellsRan Tao, Edwin F de Zoeten, Engin Ozkaynak, et al.
The Lancet. Oncology|March 1, 2020
Camrelizumab in patients with previously treated advanced hepatocellular carcinoma: a multicentre, open-label, parallel-group, randomised, phase 2 trialShukui Qin, Zhenggang Ren, Zhiqiang Meng, et al.
Nucleic Acids Research|January 9, 2015
DNA binding by FOXP3 domain-swapped dimer suggests mechanisms of long-range chromosomal interactionsYongheng Chen, Chunxia Chen, Zhe Zhang, et al.
International Journal of General Medicine|October 11, 2023
One-Year Survival for Developing Acute Kidney Injury in Adult Patients with AMI Cardiogenic Shock Receiving Venoarterial Extracorporeal Membrane OxygenationWan Chen, Mingyu Pei, Chunxia Chen, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 1, 2009
FOXP3 inhibits activation-induced NFAT2 expression in T cells thereby limiting effector cytokine expressionTroy R Torgerson, Anna Genin, Chunxia Chen, et al.
International Journal of Cancer|October 21, 2021
Camrelizumab for relapsed or refractory classical Hodgkin lymphoma: Extended follow-up of the multicenter, single-arm, Phase 2 studyJianqiu Wu, Yuqin Song, Xinchuan Chen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 18, 2019
A Single-Arm, Multicenter, Phase II Study of Camrelizumab in Relapsed or Refractory Classical Hodgkin LymphomaYuqin Song, Jianqiu Wu, Xinchuan Chen, et al.
Pageof 27

Showing results (241-250 of 264) with videos related to

Sort By:
Pageof 27
Journal for Immunotherapy of Cancer|June 21, 2023
Discovery of a novel dual-targeting D-peptide to block CD24/Siglec-10 and PD-1/PD-L1 interaction and synergize with radiotherapy for cancer immunotherapyWenhui Shen, Peishang Shi, Qingyu Dong, et al.
International Journal of Biological Macromolecules|October 20, 2018
Yulangsan polysaccharide inhibits 4T1 breast cancer cell proliferation and induces apoptosis in vitro and in vivoNi Qin, Shiyin Lu, Ning Chen, et al.
Acta Pharmaceutica Sinica. B|September 30, 2021
Tryptophan 2,3-dioxygenase 2 controls M2 macrophages polarization to promote esophageal squamous cell carcinoma progression <i>via</i> AKT/GSK3<i>β</i>/IL-8 signaling pathwayYumiao Zhao, Jiaxin Sun, Yin Li, et al.
Nature Medicine|October 9, 2007
Deacetylase inhibition promotes the generation and function of regulatory T cellsRan Tao, Edwin F de Zoeten, Engin Ozkaynak, et al.
The Lancet. Oncology|March 1, 2020
Camrelizumab in patients with previously treated advanced hepatocellular carcinoma: a multicentre, open-label, parallel-group, randomised, phase 2 trialShukui Qin, Zhenggang Ren, Zhiqiang Meng, et al.
Nucleic Acids Research|January 9, 2015
DNA binding by FOXP3 domain-swapped dimer suggests mechanisms of long-range chromosomal interactionsYongheng Chen, Chunxia Chen, Zhe Zhang, et al.
International Journal of General Medicine|October 11, 2023
One-Year Survival for Developing Acute Kidney Injury in Adult Patients with AMI Cardiogenic Shock Receiving Venoarterial Extracorporeal Membrane OxygenationWan Chen, Mingyu Pei, Chunxia Chen, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 1, 2009
FOXP3 inhibits activation-induced NFAT2 expression in T cells thereby limiting effector cytokine expressionTroy R Torgerson, Anna Genin, Chunxia Chen, et al.
International Journal of Cancer|October 21, 2021
Camrelizumab for relapsed or refractory classical Hodgkin lymphoma: Extended follow-up of the multicenter, single-arm, Phase 2 studyJianqiu Wu, Yuqin Song, Xinchuan Chen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 18, 2019
A Single-Arm, Multicenter, Phase II Study of Camrelizumab in Relapsed or Refractory Classical Hodgkin LymphomaYuqin Song, Jianqiu Wu, Xinchuan Chen, et al.
Pageof 27